MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/sla.0000000000006129

Медицинская библиотека · Annals of surgery · 2023

The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection.

Finton Sarah, Bolm Louisa, Nebbia Martina, Petruch Natalie, Férnandez-Del Castillo Carlos, Qadan Motaz, Lillemoe Keith D, Wellner Ulrich F, Distler Marius, Zimmermann Carolin, Weitz Jürgen, Rückert Felix, Rahbari Nuh N, Reissfelder Christoph, Nappo Gennaro, Keck Tobias, Zerbi Alessandro, Ferrone Cristina R

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To define the role of adjuvant therapy in duodenal adenocarcinoma (DAC) and intestinal subtype ampullary carcinoma (iAC).

BACKGROUND

DAC and iAC share a similar histologic differentiation but the benefit of adjuvant therapy remains unclear.

METHODS

Patients undergoing curative intent surgical resection for DAC and iAC between 2010 and 2021 at 5 high-volume centers were included. Patient baseline, perioperative, and long-term oncological outcomes were evaluated. Statistical testing was performed with SPSS 25 (IBM).

RESULTS

A total of 136 patients with DAC and 171 with iAC were identified. Patients with DAC had more advanced tumors than those with iAC. Median overall survival (OS) in patients with DAC was 101 months versus 155 months for patients with iAC ( P = 0.098). DAC had a higher rate of local (14.1% vs 1.2%, P < 0.001) and systemic recurrence (30.4% vs 3.5%, P < 0.001). Adjuvant therapy failed to improve OS in all patients with DAC and iAC. For DAC, patients with perineural invasion, but not other negative prognostic factors, had improved OS rates with adjuvant therapy (72 vs 44 m, P = 0.044). Patients with iAC with N+ (190 vs 57 m, P = 0.003), T3-T4 (177 vs 59 m, P = 0.050), and perineural invasion (150 vs 59 m, P = 0.019) had improved OS rates with adjuvant therapy.

CONCLUSIONS

While adjuvant therapy fails to improve OS in all patients with DAC and iAC in the current study, it improved OS in patients with DAC with perineural invasion and in patients with iAC with T3-T4 tumors, positive lymph nodes, and perineural invasion.

Для цитирования: Finton Sarah, Bolm Louisa, Nebbia Martina, Petruch Natalie, Férnandez-Del Castillo Carlos, Qadan Motaz, Lillemoe Keith D, Wellner Ulrich F, Distler Marius, Zimmermann Carolin, Weitz Jürgen, Rückert Felix, Rahbari Nuh N, Reissfelder Christoph, Nappo Gennaro, Keck Tobias, Zerbi Alessandro, Ferrone Cristina R. The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection.. Annals of surgery. 2023. DOI: 10.1097/sla.0000000000006129.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.